Cargando…
A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines
Background: Osteosarcoma (OS) represents a rare cancer with an unfavorable prognosis that needs innovative treatment. The aim was to isolate a secretome from mesenchymal stem cells (MSCs) that are treated with paclitaxel (PTX)-containing microvesicles as a drug delivery system and analyze its cytoto...
Autores principales: | Banche Niclot, Alessia Giovanna Santa, Marini, Elena, Ferrero, Ivana, Barbero, Francesco, Rosso, Elena, Fenoglio, Ivana, Barge, Alessandro, Pessina, Augusto, Coccè, Valentina, Paino, Francesca, Mareschi, Katia, Fagioli, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537652/ https://www.ncbi.nlm.nih.gov/pubmed/37765308 http://dx.doi.org/10.3390/pharmaceutics15092340 |
Ejemplares similares
-
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo-Secretome Isolated by Ultrafiltration
por: Mareschi, Katia, et al.
Publicado: (2022) -
Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions
por: Mareschi, Katia, et al.
Publicado: (2020) -
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
por: Mareschi, Katia, et al.
Publicado: (2022) -
State of the Art and New Trends from the 2022 Gism Annual Meeting
por: Ferrero, Ivana, et al.
Publicado: (2023) -
Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
por: Tirtei, Elisa, et al.
Publicado: (2021)